Cirugía de Ross en Chile: Tasa libre de reoperación y supervivencia global en una cohorte de más de 10 años de seguimiento

Antecedentes: El autoinjerto de válvula pulmonar (VP) u operación de Ross (OpR) tiene excelentes resultados a largo plazo. Es superior a otros tipos de reemplazo valvular en jóvenes adultos, aunque no el estándar de primera línea. Un tiempo quirúrgico prolongado o alta morbimortalidad son importantes preocupaciones. Objetivos: Establecer la morbimortalidad asociada a la OpR por un período >10 años, considerando el tiempo quirúrgico, tasa de reoperación y supervivencia global (SG). Métodos: Cohorte prospectiva (1996-2012), en seguimiento hasta agosto-2023. La SG fue estimada desde la OpR hasta la última consulta o deceso. Mediante regresión de Cox (Hazard Ratio, HR) se estimaron factores asociados a la SG. Resultados: La serie consta de 161 pacientes: 118 de etiología congénita (73.3%), 17 infecciosa (10.6%), 26 reumática (16.1%). La lesión fue estenótica en 79 (49.1%), insuficiencia en 40 (24.8%), mixta en 42 (26.1%). La OpR fue urgente en 11 (6.8%). The median time of ECC and the operation was 149 y 232 minutos, respectivamente. Veintisiete pacientes requirieron reoperación (16.8%). Con una mediana de 19.7 años (17.2-22.2), 23 pacientes fallecieron (14.3%): 1/23 asociado a OpR, 17/23 por causa cardiovascular y 5/23 por causas no cardiovasculares. La lesión mixta se asoció a mayor mortalidad (HR 3.07; IC 95% 1.11-8.47; p=.029). Conclusiones: La OpR es un procedimiento con baja morbimortalidad. La lesión mixta es un factor de riesgo independiente de mayor mortalidad. Sin embargo, la mediana de tiempo de CEC y quirúrgico es prolongado frente a otras técnicas de reemplazo valvular.

Background: Pulmonary valve (PV) autograftor reoperation or Ross surgery (RS), presents excellent long-term results. It is superior to other types of PV replacement in young adults, although it is not the first-line gold standard. A longer operative time or high morbidity and mortality rates are important concerns. Aim: To establish the morbidity and mortality associated with RS for >10 years, considering operative time, reoperation rate and overall survival (OS). Methods: Prospective cohort (1996-2012), with a follow-up until August/2023. The OS was estimated from RS to the last consultation/death. Factors associated to OS were estimated using Cox regression (Hazard Ratio, HR) Results: 161 patients were included: the etiology was congenital (118, 73%), infectious (17, 10.6%), and rheumatic (26,16.1%). The lesion was stenotic in 79 (49.1%), heart failure in 40 (24.8%), mixed in 42 (26.1%). RS was urgent in 11 (6.8%). Extracorporeal circulation (ECC) and operative times were 149 and 232 minutes, respectively. Twenty-seven patients required reoperation (16.8%). With a median follow up of 19.7 years (17.2-22.2), 23 patients died (14.3%): 1/23 associated with RS, 17/23 due to cardiovascular causes, and 5/23 due to non-cardiovascular causes. Mixed injury was associated with higher mortality (HR 3.07; 95% CI 1.11-8.47; p=.029). Conclusions: RS is a procedure with low morbidity and mortality. Mixed injury is an independent risk factor for increased mortality. However, the median ECC and operative times were higher compared to other valvular replacement techniques.

Gold in the dust: the re-evaluation of early surgical results of Ross procedure for aortic valve disease in children / 中华胸心血管外科杂志

Objective:To study the surgical results of Ross procedure in pediatric patients. We report our early outcomes of the Ross procedure for congenital aortic valve disease.Methods:Retrospective analysis was performed on all 16 children with congenital aortic valve disease that underwent a Ross procedure from May 2018 to December 2019. Three patients had aortic stenosis(AS), 5 had aortic regurgitation(AR), and 8 patients had AS/AR. Two patients had endocarditis. Nine patients had prior aortic valve surgeries or interventions, 7 had percutaneous balloon aortic valvuloplasty, 1 had surgical valvotomy and 1 had aortic valve repair by cusp extension. Six patients had bicuspid and 1 had quadricuspid aortic valves.Results:There was no early death. Mean CPB time was (193.8±66.9) min (range 123~359 min), mean aortic cross-clamping time was (125.9±29.7) (range 82-186 min). Mean ventilation time was (58.0±42.4) h (range 22.7-163.0 h), and mean ICU and hospital length of stay was (5.4±3.4) d (range 2-16 d) and (25.9±18.7) d (range 7-77d). Six patients developed low cardiac output syndrome and 2 patient had hepatic dysfunction, which all improved after treatment. Follow-up was complete in all patients from 3 to 23 months, and there was no late death. Thirteen patients were in NYHA grade Ⅰ, and 3 in grade Ⅱ. The peak gradients through the aortic valve and pulmonary valve were (8.3±5.5)mmHg (3.7-26.6mmHg) and (20.5±16.4) mmHg (6.8-62.1 mmHg), respectively. The aortic regurgitation was negative in 3 patients, trivial in 1 patient and mild in 12 patients. The pulmonary regurgitation was trivial in 4 patients, mild in 9 patients and moderate in 3 patients.Conclusion:Ross procedure is a safe, effective surgical operation for congenital aortic valve disease in children >1-year of age.

Surgical Outcomes and Autograft Function after the Ross Procedure in Neonates and Infants / 日本心臓血管外科学会雑誌

Objective: In Japan, only a few reports of the Ross procedure in neonates and infants have been published. The objective of this study was to evaluate the outcome of patients undergoing a Ross procedure before the age of one year, and to review the validity of opting for this procedure at this age. Methods: The records of 13 infants (including three neonates) undergoing a Ross procedure between December 1996 and June 2017 were reviewed. Major outcomes studied included graft-associated morbidity, autograft function, and the need for reoperation. Results: The median age at the time of Ross procedure was 166 days, and median weight was 5.7 kg. Primary diagnoses were aortic stenosis in 10 cases and aortic insufficiency in three. Nine cases required emergent Ross procedure due to left ventricular dysfunction refractory to medication, requirement of mechanical ventilation or intravenous inotropic drugs. Concomitant procedures included three aortic coarctation repairs, two annular enlargement procedures with a Konno incision and one each of aortic and mitral annuloplasty. The mean cross-clamp time was 131 min and the mean extracorporeal circulation time was 178 min. Two cases required extracorporeal membrane oxygenation. Seven underwent delayed sternal closure and four required postoperative peritoneal dialysis. The median duration of mechanical ventilation was five days and the median length of intensive care unit stay was seven days. Survival was 100% at a median follow-up of 9.9 years. The diameter of the aortic annulus mostly stayed within normal limits, although sinus of Valsalva's enlargement beyond normal value was noted in some cases. Trans-aortic valve pressure gradient was less than 20 mmHg and aortic insufficiency was less than mild in all cases, thus requiring no reintervention for the valve. Two cases required coronary arterial bypass and release of the subaortic stenosis. Freedom from reoperation for the left heart was 100% at one year, and 81.5% at five years and 10 years. Ten cases required reoperation for the right heart, and freedom from reoperation was 84.6% at one year, 29.7% at five years and 9.9% at 10 years. Conclusion: Durability of the pulmonary autograft was excellent. The Ross procedure can be an effective treatment strategy for severe aortic valve diseases in neonates and infants.

Advances in aortic valve replacement in children / 中华实用儿科临床杂志

Several disease pathologies can affect the aortic valve(AV)in children frequently necessitating in-tervention. Several developments in interventional cardiology and AV repair techniques demonstrated encouraging short - term and mid - term results in children with AV disease. Current evidence supports valvular repair is the goal of intervention in children with AV disease. When reconstruction fails or intervention failure,valve replacement becomes inevitable. The studies about AV replacement in children are not rare. This aim of article is to make a review of related researches in recent years.

Post ross procedure aortic right sinus of valsalva fistula to right ventricle / Seno de valsalva aórtico derecho con fístula a ventrículo derecho tras el procedimiento ross

Post Ross procedure complications have been limited predominantly to neoaortic valvular dilatation (10-30%) and insufficiency, right ventricular prosthetic deterioration or right ventricular pulmonary artery conduit obstruction. Arrhythmia has been documented to occur in a third of these patients. This is the first time that neoaortic right sinus of valsalva dissection and rupture to the right ventricle with a fistulous communication has occurred and been described, as far as the author is aware.

Las complicaciones tras el procedimiento Ross han estado limitadas predominantemente a la dilatación (10-30%) e insuficiencia de la válvula neoaórtica, el deterioro prostético ventricular derecho, o la obstrucción del conducto de la arteria pulmonar derecha. Se ha documentado la presencia de arritmia en un tercio de estos pacientes. Hasta donde el autor conoce, esta es la primera vez que se produce y se describe la disección y ruptura de un seno de Valsalva aórtico derecho a ventrículo derecho con comunicación fistulosa.

Aortic Valve Replacement by Pulmonary Autogrbft: Technical Advances and Follow-up.

Background: Autograft is the best choice of graft material in every place especially in cardiac surgery to avoid all type of anti-coagulant related hazard, immunological reactions and considering cost involvement. Study was designed on the basis of above facts. Methods: All patients underwent surgery with standard Cardiopulmonary By-pass under moderate hypothermia using median stemotomy incision. Aortic valve was excised and the right and left coronary buttons were fashioned. Also the pulmonary root was excised. A running suture technique was used to insert the autograft in to the aortic annulus. A pulmonary homograft made by pericardium with three pulmonary valves of appropriate size (22-29 mm) was then inserted. Results: Between July 2001 to July 2002, 30 patients underwent the modified Ross Procedure at La- Pitie Salpitriere Hospital, Paris, France. Out of 30 patients 16 were male and 14 were female with the mean age of 29 years. Indication of operation was aortic stenosis in 6 cases, aortic insufficiency in 9 cases and mixed aortic valve lesion in 15 cases. The mean intra operative cross clamp time was 120 minutes (range: 70-170 minutes), mean cardiopulmonary bypass time was 150 minutes (range: 110- 195 minutes). Postoperativee chocardiogramsr evealed no significant pulmonary or aortic valvular dysfunction. Three patients, early in the series required reopening for post operative bleeding. Overall a mean of 2.5 units of bloods (0-10) were transfused per patient. Atrial fibrillation occurred in 2 patients which wsre managed accordingly. Among 30 patients, there was one perioperative death (3%), one patient was lost to follow-up and one patient refused to late post operative echocardiography. Twenty four caseso ut of the twenty seven patients available for functional follow-up were in NYHA class I, 2 patients in NYHA class II and one patient in NYHA class III. Conclusions: Pulmonary autografts in aortic position give good short-term result but for its long {erm effrcacy and safety needs more study.

Reemplazo valvular aórtico utilizando la cirugía de Ross: 13 años de experiencia / Aortic Valve Replacement Using the Ross Procedure: a 13-Year Experience

Introducción El procedimiento de Ross para el tratamiento de la valvulopatía aórtica se ha utilizado durante décadas. A pesar de sus resultados alentadores, ciertos interrogantes han limitado su uso masivo; su durabilidad es uno de los principales motivos de preocupación. Objetivo Analizar los resultados de la cirugía de Ross en nuestro centro. Material y métodos El presente es un estudio de cohorte retrospectivo. De julio de 1995 a mayo de 2008, 198 pacientes fueron sometidos a cirugía de Ross; en todos ellos se empleó la técnica de reemplazo de la raíz aórtica. Los eventos asociados con la válvula se analizaron con el método de Kaplan-Meier. Para el análisis de las variables se emplearon el log-rank test y el modelo de Cox. Resultados La edad media fue de 39 ± 13 años; el 77% eran hombres. La cirugía fue indicada por estenosis aórtica (58%) e insuficiencia aórtica (42%). La mortalidad hospitalaria fue del 2,5% (5 pacientes). El seguimiento a 10 años fue completo en el 93% para los primeros 165 pacientes. La sobrevida a los 10 años fue del 94,8% (IC 95% 89-98). La libertad de endocarditis a los 10 años fue del 95% (IC 95% 84-98) y la libertad de eventos relacionados con la válvula a los 10 años fue del 91% (IC 95% 86-96). Cinco pacientes requirieron reoperación, 4 de ellos por disfunción del autoinjerto y enfermedad de otras válvulas. Conclusiones La cirugía de Ross es una técnica quirúrgica con una tasa baja de eventos a los 13 años y debe ser considerada para el tratamiento de la enfermedad valvular aórtica en pacientes seleccionados.

Background The Ross procedure has been used for decades for the treatment of aortic valve disease. Despite the promising outcomes of this technique, its limited durability is one of the major drawbacks against its massive indication. Objective To analyze the outcomes of the Ross procedure in our oenter. Material and Methods We conducted a retrospective study in a cohort of patients. From July 1995 to May 2008, 198 patients underwent Ross procedure with aortic root replacement technique. Kaplan-Meier method was used to analyze the events associated with the valve, and the variables were analyzed using the log-rank test and Cox model. Results Mean age was 39± 13 years and 77% were raen. The procedure was indicated due to aortic stenosis (58%) and aortic regurgitation (42%). In-hospital mortality was 2.5% (5 patients). Complete follow-up at 10 years was achieved in 93% of the first 165 patients. Survival at 10 years was 94.8% (95% CI, 89-98) After 10 years, 95% (95% CI, 84-98) of patients did not present endocarditis and 91% (95% CI, 86-96) had no valve-related events. Five patients required reoperation, 4 due to autograft dysfunction and disease of other valves. Conclusions Ross procedure has a low event rate after 13 years and should be considered for the treatment of aortic valve disease in selected patients.

Clinical Experiences of Congenital Aortic Stenosis / 대한흉부외과학회지

BACKGROUND: The aim of this study is to assess the clinical results of various procedures in congenital aortic stenosis. MATERIAL AND METHOD: From August 1987 to June 2004, 53 patients of congenital aortic stenosis underwent procedures such as percutaneous balloon valvuloplasty, aortic valvuloplasty, Ross procedure, and aortic valve replacement. The mean age of initial procedures was 8.2+/-6.0 years. Percutaneous balloon valvuloplasty was performed in sixteen patients, aortic valvuloplasty in thirty two patients, Ross procedure in nineteen patients, and aortic valve replacement in fourteen patients. The mean follow duration was 80.6+/-60 (0~207) months. RESULT: There was 15.1% (8/53) of early mortality and no late mortality. The six patients with critical aortic stenosis were died of left ventricular dysfunction in early series (before 1 year; 4 cases) and two patients died after the Ross procedure and aortic valve replacement respectively. After percutaneous balloon valvuloplasty, most patients needed reoperations (14/16). Thirteen patients needed reoperation, after aortic valvuloplasty. After Ross procedure, two patients needed reoperation due to aortic regurgitation caused by progressive aortic root dilatation. The actuarial survival rate after Ross procedure at 7 years was 90.5%. CONCLUSION: In young children before the age of one, percutaneous balloon valvuloplasty was considered as the safe initial palliative procedure. But children over one year-old, aortic valvuloplasty were the effective procedure. Ross procedure can be preformed safely with good results.

Mid-term Results of the Ross Procedure / 대한흉부외과학회지

BACKGROUND: Ross procedure is ideal aortic valve replacement method with several merits of hemodynamic superiority and durability without the need of anticoagulation. Based upon this presumption, we studied its procedure performed in our hospital and tried to get the mid-term results MATERIAL AND METHOD: From Jan 1999 to Oct 2001, 22 patients underwent the Ross procedure. The mean age of experimented (including 17 men and 5 women) was 30.9+/-8.1 (17~44). The diagnosis before the surgery had shown 20 as accompanied with AR and the rest 2 as with ASR. The follow-up period ranged from 0.6 to 40.6 months, mean of 38.9+/-1.6 months, and follow-up rate was 100%. RESULT: There was no operative death and two late deaths, one of whom was cardiac originated and the other, non-cardiac relate The survival rate was 94.1+/-5.7% (40.6 months). Postoperatively there were 2 exploration for bleeding, 3 low cardiac output patients. The pulmonary autograft technique was root replacement in 14 and inclusion technique in 8. Pulmonary homografts were used at the pulmonary position in all cases. There was no patient with significant aortic regurgitation. CONCLUSION: These showed that the mortality and morbidity of the Ross procedure were acceptable and postoperative AR was not significant. However, further long-term follow-up will be necessary for the improvement of the function of pulmonary autograft and homograft.

Early Failure of the Shelhigh Pulmonary Valve Conduit in Ross Operation: Two case reports / 대한흉부외과학회지

It is very difficult to choose the ideal valved conduit used in right ventricle outflow reconstruction in child. We can use the cryopreserved homograft but there is a limit of appplication because of its difficulties in the size matching and supply capacity. The Shelhigh(R) porcine-valved conduit is commercially available and used as an alternative choice in these days. We report two cases of early Shelhigh conduit failure in right ventricular outflow tract after Ross operation in congenital aortic stenosis.